Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 23, 2008View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 23, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 9, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 25, 2008View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 24, 2008View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 7, 2008View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerNov 6, 2008Download DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2008View HTMLDownload DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECNov 4, 2008View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 28, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 23, 2008View HTMLDownload DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECOct 16, 2008View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GOct 10, 2008View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerOct 7, 2008Download DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2008View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-152

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information